Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Warnings Patients who have early Leber's disease (LHON) a hereditary disease that causes optic nerve atrophy have been found to suffer severe and swift optic atrophy when treated with vitamin B12
Moreover, accessibility issues may arise for individuals in remote areas or those with limited mobility, making regular injections less feasible
Here are some times to consider changing the dose: If treatment isnt working well, increase the dose or how often its given If B12 levels are too high, lower the dose Change the dose if the patients health changes or new issues come up By sticking to these guidelines, doctors can make B12 treatment better for each patient
5-Amino-1MQ is a first-in-class small molecule inhibitor designed to target Nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that acts as a master regulator of the cellular "metabolic drain."
US$ 22.05
US$ 28.30
US$ 21.75
